Hot flash relief for Indian women in menopause
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study tests a non-hormonal pill called fezolinetant to see if it reduces hot flashes in Indian women going through menopause. It may offer a new option for women who cannot or prefer not to use hormone therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman going through menopause, either naturally or due to surgery.
- You have at least 7 moderate to severe hot flashes per day on average.
- You are generally healthy and have no serious medical conditions.
- You have not used hormone therapy or other hot flash treatments recently.
- You are not pregnant and are willing to use contraception if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows women in Canada who are starting fezolinetant, a new medication for hot flashes during menopause. Researchers will track how well it works and how you feel while using it in your regular doctor's care.
This study tests a medication called fezolinetant to see if it reduces hot flashes in men undergoing hormone therapy for prostate cancer. If you experience frequent hot flashes, this treatment might help alleviate them.
This trial tests whether a dietary supplement can reduce hot flashes in women who are in late perimenopause or early postmenopause. If you are experiencing frequent hot flashes, this could help you find relief.
This study tests whether strength training or high-intensity aerobic exercise can reduce hot flashes in postmenopausal women. You would exercise 3 times a week for 15 weeks to see if it helps your symptoms.
This study tests a medication called fezolinetant to see if it helps with hot flashes and also looks at its effects on blood vessels and the brain. It is for women who are going through menopause and having frequent moderate to severe hot flashes.
This trial tests a drug called fezolinetant to see if it reduces hot flashes in women with HR+ breast cancer who are on hormone therapy (like tamoxifen or aromatase inhibitors). You need to be postmenopausal and having at least 7 moderate to severe hot flashes a day.
Hear when a new Hot Flashes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.